Ignite Creation Date:
2024-05-05 @ 5:17 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00425750
Status:
COMPLETED
Last Update Posted:
2011-11-16
First Post:
2007-01-19
Brief Title:
Bortezomib and Docetaxel in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Sponsor:
Vanderbilt-Ingram Cancer Center
Organization:
Vanderbilt-Ingram Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Head and Neck Cancer |
Keywords:
| Name | View |
|---|---|
| stage IV squamous cell carcinoma of the lip and oral cavity | View |
| recurrent squamous cell carcinoma of the lip and oral cavity | View |
| stage IV squamous cell carcinoma of the oropharynx | View |
| recurrent squamous cell carcinoma of the oropharynx | View |
| stage IV squamous cell carcinoma of the hypopharynx | View |
| recurrent squamous cell carcinoma of the hypopharynx | View |
| stage IV squamous cell carcinoma of the larynx | View |
| recurrent squamous cell carcinoma of the larynx | View |